0001144204-17-031582.txt : 20170607
0001144204-17-031582.hdr.sgml : 20170607
20170607174324
ACCESSION NUMBER: 0001144204-17-031582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160930
FILED AS OF DATE: 20170607
DATE AS OF CHANGE: 20170607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSTANG BIO, INC.
CENTRAL INDEX KEY: 0001680048
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473828760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0312
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 7816524507
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55668
FILM NUMBER: 17898182
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER NAME:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
v467961_form4.xml
FORM 4
X0306
4
2016-09-30
0
0001680048
MUSTANG BIO, INC.
NONE
0001429260
Fortress Biotech, Inc.
2 GANSEVOORT STREET
9TH FLOOR
NEW YORK
NY
10014
0
0
1
0
Common Stock, $0.0001 par value
2016-09-30
4
A
0
47870
0.00
A
9047870
D
Common Stock, $0.0001 par value
2016-10-25
4
A
0
27264
0.00
A
9075134
D
Common Stock, $0.0001 par value
2016-11-30
4
A
0
47505
0.00
A
9122639
D
Common Stock, $0.0001 par value
2016-12-12
4
A
0
11925
0.00
A
9134564
D
Common Stock, $0.0001 par value
2016-12-29
4
A
0
15806
0.00
A
9150370
D
Common Stock, $0.0001 par value
2017-01-31
4
A
0
213419
0.00
A
9363789
D
Common Stock, $0.0001 par value
2017-03-13
4
A
0
767264
0.00
A
10131053
D
Common Stock, $0.0001 par value
2017-03-31
4
A
0
1600
0.00
A
10132653
D
Class A Preferred Stock, $0.0001 par value
Common Stock
250000
250000
D
The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the closing of an equity financing.
The Reporting Person is entitled to an annual dividend on its outstanding Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on March 13. These shares were granted by the Issuer to the Reporting Person for the 2017 annual dividend.
Each share of the Issuer's Class A Preferred Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.
/s/ Lindsay A. Rosenwald, Chairman, President and Chief Executive Officer
2017-06-07